Literature DB >> 18540734

Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression.

Alex J Zautra1, Mary C Davis1, John W Reich1, Perry Nicassario2, Howard Tennen3, Patrick Finan1, Anna Kratz1, Brendt Parrish1, Michael R Irwin2.   

Abstract

This research examined whether cognitive behavioral therapy and mindfulness interventions that target responses to chronic stress, pain, and depression reduce pain and improve the quality of everyday life for adults with rheumatoid arthritis (RA). The 144 RA participants were clustered into groups of 6-10 participants and randomly assigned to 1 of 3 treatments: cognitive behavioral therapy for pain (P); mindfulness meditation and emotion regulation therapy (M); or education-only group (E), which served as an attention placebo control. The authors took a multimethod approach, employing daily diaries and laboratory assessment of pain and mitogen-stimulated levels of interleukin-6 (IL-6), a proinflammatory cytokine. Participants receiving P showed the greatest Pre to Post improvement in self-reported pain control and reductions in the IL-6; both P and M groups showed more improvement in coping efficacy than did the E group. The relative value of the treatments varied as a function of depression history. RA patients with recurrent depression benefited most from M across several measures, including negative and positive affect and physicians' ratings of joint tenderness, indicating that the emotion regulation aspects of that treatment were most beneficial to those with chronic depressive features. (c) 2008 APA, all rights reserved

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18540734     DOI: 10.1037/0022-006X.76.3.408

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  109 in total

1.  Mindfulness and cognitive-behavioral interventions for chronic pain: differential effects on daily pain reactivity and stress reactivity.

Authors:  Mary C Davis; Alex J Zautra; Laurie D Wolf; Howard Tennen; Ellen W Yeung
Journal:  J Consult Clin Psychol       Date:  2014-11-03

Review 2.  Sleep disturbance, inflammation and depression risk in cancer survivors.

Authors:  Michael R Irwin; Richard E Olmstead; Patricia A Ganz; Reina Haque
Journal:  Brain Behav Immun       Date:  2012-05-24       Impact factor: 7.217

Review 3.  Psychosocial factors and adjustment to chronic pain in persons with physical disabilities: a systematic review.

Authors:  Mark P Jensen; Michael R Moore; Tamara B Bockow; Dawn M Ehde; Joyce M Engel
Journal:  Arch Phys Med Rehabil       Date:  2011-01       Impact factor: 3.966

Review 4.  Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?

Authors:  David Baumeister; Simone Ciufolini; Valeria Mondelli
Journal:  Psychopharmacology (Berl)       Date:  2015-08-14       Impact factor: 4.530

Review 5.  Inflammation: depression fans the flames and feasts on the heat.

Authors:  Janice K Kiecolt-Glaser; Heather M Derry; Christopher P Fagundes
Journal:  Am J Psychiatry       Date:  2015-09-11       Impact factor: 18.112

Review 6.  Pain, catastrophizing, and depression in the rheumatic diseases.

Authors:  Robert R Edwards; Christine Cahalan; Christine Calahan; George Mensing; Michael Smith; Jennifer A Haythornthwaite
Journal:  Nat Rev Rheumatol       Date:  2011-02-01       Impact factor: 20.543

7.  From the clinic to the lab (and back)-a call for laboratory research to optimize cognitive behavioural treatment of pain.

Authors:  Stefaan Van Damme; David J Moore
Journal:  Transl Behav Med       Date:  2012-03       Impact factor: 3.046

8.  Toward identifying the effects of the specific components of Mindfulness-Based Stress Reduction on biologic and emotional outcomes among older adults.

Authors:  Autumn M Gallegos; Michael Hoerger; Nancy L Talbot; Michael S Krasner; Jennifer M Knight; Jan A Moynihan; Paul R Duberstein
Journal:  J Altern Complement Med       Date:  2013-02-05       Impact factor: 2.579

9.  Determinants of pain treatment response and nonresponse: identification of TMD patient subgroups.

Authors:  Mark D Litt; Felipe B Porto
Journal:  J Pain       Date:  2013-10-02       Impact factor: 5.820

Review 10.  Mindfulness meditation for substance use disorders: a systematic review.

Authors:  Aleksandra Zgierska; David Rabago; Neharika Chawla; Kenneth Kushner; Robert Koehler; Alan Marlatt
Journal:  Subst Abus       Date:  2009 Oct-Dec       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.